Sponsor hub
University of Arkansas clinical trial failures
Review 37 stopped clinical trials from University of Arkansas, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 2 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 25
- OTHER/UNKNOWN
- 10
- EFFICACY/FUTILITY
- 1
- SAFETY
- 1
Notable sponsors
- University of Arkansas
- 37
Related phases
- Phase II
- 16
- Phase I
- 9
- Phase IV
- 4
- Unknown
- 4
- Early Phase I
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 37 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase I Parkinson Disease trial by University of Arkansas. Stop reason: OPERATIONAL.
project not funded
Phase I Lung Neoplasms trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Inability to enroll subjects under current iteration of the protocol
Phase II Vaginal Atrophy trial by University of Arkansas. Stop reason: OPERATIONAL.
Low recruitment/enrollment
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
Study was not and will not be initiated due to lack of funding.
Phase II Covid19 trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
PI no longer wanted to do the study
Phase II Neoplasms by Site trial by University of Arkansas. Stop reason: OPERATIONAL.
Lack of Funding
Phase I Acute Kidney Injury trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Data no longer support this study
Phase I Gastroschisis trial by University of Arkansas. Stop reason: OPERATIONAL.
COVID-19 pandemic
Early Phase I Squamous Cell Carcinoma of the Head and Neck trial by University of Arkansas. Stop reason: OPERATIONAL.
Study has been open for 8 years with no enrollment. Procedures in 2013 protocol are outdated. Cannot make the radiopharmaceutical on campus anymore.
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
Low enrollment and Futility as determined by Amgen's Carfilzomib NASCR program.
Phase II Metastatic Breast Cancer trial by University of Arkansas. Stop reason: OPERATIONAL.
FDA approved higher dose of study drug. Dose used in protocol lower than SOC - enrollment stopped, those on treatment were given option to opt out.
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Withdrawal of study support
Phase II Pancreatic Cancer trial by University of Arkansas. Stop reason: OPERATIONAL.
no subjects enrolled
Phase II Breast Cancer trial by University of Arkansas. Stop reason: OPERATIONAL.
Lack of funding/ PI leaving institution
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
No study population. No subjects enrolled.
Phase IV Breast Neoplasm trial by University of Arkansas. Stop reason: EFFICACY/FUTILITY.
PI is no longer at institution. IRB closed study due to lack of response from PI
Phase IV Major Depression trial by University of Arkansas. Stop reason: OPERATIONAL.
Study stopped due to difficulty recruiting
Phase IV Agitation,Psychomotor trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Sponsor Withdrawal
Phase IV Shock, Septic trial by University of Arkansas. Stop reason: OPERATIONAL.
PI left
Phase II Methamphetamine Dependence trial by University of Arkansas. Stop reason: OPERATIONAL.
Terminated due to lack of funding.
Phase III Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
low accrual
Phase III Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
Due to poor accrual
Phase II Autism Spectrum Disorder trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Non-compliance
Phase I Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
Due to poor accrual
Early Phase I Postdural Puncture Headache trial by University of Arkansas. Stop reason: OPERATIONAL.
Study stopped due to difficulty recruiting patients
Unknown Hernia trial by University of Arkansas. Stop reason: OPERATIONAL.
difficult recruitment
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
Investigator decided to close study without enrollment
Unknown Constipation trial by University of Arkansas. Stop reason: OPERATIONAL.
Lack of recruitment
Phase II Colorectal Neoplasms trial by University of Arkansas. Stop reason: OPERATIONAL.
Inadequate accrual
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
PI left institution
Phase I Tinnitus trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Terminated early due to lack of change in primary and secondary outcome measures.
Phase II Multiple Myeloma trial by University of Arkansas. Stop reason: OPERATIONAL.
Slow accrual; PI left primary institution
Phase I Rectal Cancer trial by University of Arkansas. Stop reason: OPERATIONAL.
No enrollment
Phase I Breast Cancer trial by University of Arkansas. Stop reason: SAFETY.
IRB request
Unknown Tissue Lipid Metabolism trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
The study goals were accomplished by a similar study at UAMS. (W.J. Evans)
Unknown Multiple Myeloma trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
Study was terminated early because the site that administered the hyperbaric oxygen treatment closed and an alternative site could not be identified.
Phase I Multiple Myeloma trial by University of Arkansas. Stop reason: OTHER/UNKNOWN.
This study was terminated because the drug company stopped making the study drug